Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial

Open access

Abstract

OBJECTIVE: To examine whether sluggish cognitive tempo (SCT) symptomatology moderates dose response to methylphenidate and whether the impact of SCT on medication response is distinct from attention-deficit/hyperactivity disorder (ADHD) subtype effects. METHODS: Stimulant-naive children with ADHD predominantly inattentive type (ADHD-I; n = 126) or ADHD combined type (ADHD-C; n = 45) aged 7-11 years were recruited from the community from September 2006 to June 2013 to participate in a prospective, randomized, double-blind, 4-week crossover trial of long-acting methylphenidate. ADHD diagnosis and subtype were established according to DSM-IV criteria using a structured interview and teacher ADHD symptom ratings. SCT symptoms were assessed using a teacher-rated scale with 2 factors (Sluggish/Sleepy and Daydreamy). Primary outcomes included (1) categorization of children as methylphenidate responders, methylphenidate nonresponders, or placebo responders by 2 blinded physicians and (2) parent and teacher ratings of child behavior on the Vanderbilt ADHD Diagnostic Rating Scales while subjects were on treatment with placebo or 1 of 3 methylphenidate dosages (low, medium, high). RESULTS: Increased SCT Sluggish/Sleepy factor scores were associated with being a methylphenidate nonresponder or placebo responder rather than a methylphenidate responder (P = .04). Sluggish/Sleepy factor scores were also linked to diminished methylphenidate dose response for parent- and teacher-rated inattention symptoms (Sluggish/Sleepy factor × dose P = .004). SCT Daydreamy symptoms and ADHD subtype (ADHD-I vs ADHD-C) were not associated with methylphenidate responder status and did not moderate methylphenidate dose response for inattention symptoms. CONCLUSIONS: SCT Sluggish/Sleepy symptoms, but not SCT Daydreamy symptoms or ADHD subtype, predicted methylphenidate nonresponse. This novel finding, if replicated, may have important implications for assessing SCT as part of ADHD care. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01727414.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4088/jcp.17m11553

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

9 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 2

  1. [3]Safer DJ, Zito JM. Pharmacoepidemiology of Methylphenidate and Other Stimulants for the Treatment of Attention Deficit Hyperactivity Disorder. In: Greenhill L, ed. Ritalin Theory and Practice 2nd ed. Larchmont, NY: Mary Ann Liebert, Inc.; 2000: 7– 26.
  2. [22]Wechsler D Wechsler Individual Achievement Test - Second Edition (WIAT-II) San Antonio, TX: Psychological Corporation; 2001.

Cited by

See all 59

Metadata

Authors
Froehlich, T. E., Becker, S. P., Nick, T. G., Brinkman, W. B., Stein, M. A., Peugh, J., & Epstein, J. N.
Affiliations
  • Cincinnati Children's Hospital Medical Center (US)
  • University of Arkansas for Medical Sciences (US)
  • Seattle Children's Hospital (US)
Corresponding author
Froehlich, Tanya E.
Venue
The Journal of Clinical Psychiatry
Published
2018-04-25
Volume
79
Issue
2
Pages
17m11553
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2790278642
Cited by
51
References
42
Citations by year
2026: 7 · 2025: 5 · 2024: 5 · 2023: 10 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 5 · 2018: 3
FWCI
3.71
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Pfizer
  • Cincinnati Children's Hospital Medical Center
  • University of Arkansas for Medical Sciences
  • National Institute of Mental Health (K24MH064478, K23MH083881, K23MH083027, K23MH108603, R01MH070564, R01MH074770)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083091)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
  • Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
Keywords
sluggish cognitive tempo, methylphenidate response, attention deficit hyperactivity disorder, ADHD inattentive type, combined type ADHD, placebo response, dose-response relationship, inattentive symptoms, children, sleepiness, daydreaming
MeSH terms
Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Child Behavior, Child, Preschool, Cognition, Dose-Response Relationship, Drug, Double-Blind Method, Fantasy, Female, Humans, Male, Methylphenidate, Psychiatric Status Rating Scales, Treatment Outcome, Drug Monitoring, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.4088/jcp.17m11553
The paper
Froehlich, T. E., Becker, S. P., Nick, T. G., Brinkman, W. B., Stein, M. A., Peugh, J., & Epstein, J. N. (2018). Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.17m11553

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.